Picture of Alligator Bioscience AB logo

ATORX Alligator Bioscience AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Alligator Bioscience Presents New Preclinical Data At AACR

March 11 (Reuters) - Alligator Bioscience AB  ATORX.ST :
    * MITAZALIMAB SYNERGIZES WITH CHEMOTHERAPY - ALLIGATOR
BIOSCIENCE
PRESENTS NEW PRECLINICAL DATA AT AACR
    * NEW PRECLINICAL DATA ARE VERY ENCOURAGING
    * TOGETHER WITH CLINICAL DATA OF MITAZALIMAB FROM A PREVIOUS
PHASE
I STUDY DATA SUPPORT UPCOMING CLINICAL PHASE II STUDY OF
MITAZALIMAB IN COMBINATION WITH CHEMOTHERAPY IN PANCREATIC
CANCER PATIENTS

Source text for Eikon:  ID:nWkr6ns3JS 
Further company coverage:  ATORX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Alligator Bioscience AB

See all news